News Hub | News Direct

All Industries


Article thumbnail News Release

Citi Remains Tactically Bullish on Uranium; Forecasts Price Rebound in 2024

MarketJar

On behalf of Generation Uranium Inc. Uranium has been a major investment theme over the past 18 months, with prices rising from below US$60/lb to over US$107/lb in February. Although the market has declined steadily since, leading many investors to question whether to hold or exit, Citi maintains a "tactically bullish" outlook for the market’s potential in 2024 and beyond. 1 Citi's latest research attributes the recent price stagnation to low trading volume and liquidity but expects a rebound as investor focus shifts. Citi forecasts uranium prices could rise to US$98/lb later this year, with an average of US$94/lb. By 2025, prices could reach US$110/lb, implying a potential upside of 36%. Citi points to increased uranium production as a factor in the recent price dip, with Kazakhstan's output expected to reach 59 million lbs this year. However, production growth is expected to slow sharply later in the decade. Meanwhile, inventories are projected to fall by 20 million lbs by 2030, putting uranium production back at the center of price determination. On the demand side, Citi notes the growing need for low-carbon energy and rising global power consumption. While no new nuclear plants are currently planned, Citi expects utilities to focus on extending plant life and restarting shuttered facilities, potentially boosting uranium demand, especially in the US. As the broader uranium market shows signs of a potential recovery, companies like Generation Uranium (TSXV:GEN) (OTCQB:GENRF) are well-positioned to capitalize on this trend through strategic projects and exploration initiatives. Generation Uranium is making significant strides with its Yath Uranium Project in Nunavut, Canada. 2 The company holds a 100% interest in this project, which is located in the prolific and under-explored Thelon Basin. Yath is strategically positioned along the trend of the Lac 50 uranium deposit, which contains 43 million lbs of uranium and is currently being developed by Latitude Uranium, a company recently acquired by ATHA Energy for $64.7 million in an all-share deal. 3 Historical exploration at Yath has consistently indicated uranium concentrations between 1% and 10% U3O8, underscoring its potential. In June, Generation Uranium acquired the Yellow Frog and Pink Toad Uranium Projects along the Angilak Trend in Nunavut, Canada. These acquisitions expand the Company's Yath Uranium Project by over 45%, bringing its total coverage to 123.45 km². Yath now extends northward, coming within 3 kilometers of Atha Energy Corp’s Angilak Project. Generation Uranium Partners With APEX Geoscience and ATHA Energy to Advance Yath Uranium Project In a further move to advance the Yath Project, Generation Uranium (TSXV:GEN) (OTCQB:GENRF) has partnered with APEX Geoscience. APEX will provide geological consulting services and assist in preparing and submitting exploration authorization applications for a planned diamond drilling campaign. This collaboration includes coordination with key regulatory bodies such as the Nunavut Planning Commission, Nunavut Impact Review Board, and Kivalliq Inuit Association to ensure compliance with all regulations. This partnership builds on historical data pointing to significant uranium potential at Yath, with past explorations and recent surveys by Kivalliq Energy affirming the high-grade uranium deposits. The collaboration with APEX Geoscience emphasizes Generation Uranium ’s commitment to utilizing expert insights and advanced technology to maximize the Yath Uranium Project’s potential, setting the stage for future development and regional economic growth. To accelerate exploration, Generation Uranium (TSXV:GEN) (OTCQB:GENRF) has launched an advanced airborne electromagnetic survey at the Yath Project, in partnership with ATHA Energy Corp. The survey is being conducted by Expert Geophysics Ltd., a leader in geophysical survey technology, using its cutting-edge Mobile MagnetoTellurics (MMT) system. This system, known for its precision, will employ the latest airborne AFMAG (Audio-frequency Magnetic) technology to identify electromagnetic (EM) anomalies across the 123.45 km² property. The survey will cover 890 line-kilometers with a 150-meter line spacing, gathering high-resolution magnetic and VLF data. The collaboration with ATHA Energy allows Generation Uranium to leverage economies of scale, reducing costs and speeding up the exploration process. CEO Anthony Zelen expressed confidence in the project, highlighting the strategic partnership and advanced technology as key factors in advancing Yath towards drilling. Click here for more information about Generation Uranium (TSXV:GEN) (OTCQB:GENRF). [1] https://www.marketindex.com.au/news/uranium-prices-will-rise-again-remain-tactically-bullish-citi [2] https://generationuranium.com/yath-project [3] https://generationuranium.com/news/b/guexploration Disclaimer 1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on research and understanding of the sector. 2) The Article was issued on behalf of and sponsored by, Generation Uranium Inc. Market Jar Media Inc. was paid $1,500 for the production and publishing of this article by Generation Uranium Inc.’s Digital Marketing Agency of Record (Native Ads Inc.). Additional details relating to Market Jar Media Inc.’s engagement by Generation Uranium Inc.’s Digital Marketing Agency of Record (Native Ads Inc.) are set out in https://pressreach.com/disclaimer-gen. 3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. Market Jar has not independently verified or otherwise investigated all such information. None of Market Jar or any of their respective affiliates, guarantee the accuracy or completeness of any such information. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy. 4) The Article does not constitute investment advice. All investments carry risk and each reader is encouraged to consult with his or her individual financial professional. Any action a reader takes as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.'s terms of use and full legal disclaimer as set forth here. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on pressreach.com should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on pressreach.com. 5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article. 6) This document contains forward-looking information and forward-looking statements, within the meaning of applicable Canadian securities legislation, (collectively, “forward-looking statements”), which reflect management's expectations regarding Generation Uranium Inc.’s future growth, future business plans and opportunities, expected activities, and other statements about future events, results or performance. Wherever possible, words such as “predicts”, “projects”, “targets”, “plans”, “expects”, “does not expect”, “budget”, “scheduled”, “estimates”, “forecasts”, “anticipate” or “does not anticipate”, “believe”, “intend” and similar expressions or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative or grammatical variation thereof or other variations thereof, or comparable terminology have been used to identify forward-looking statements. These forward-looking statements include, among other things, statements relating to: (a) revenue generating potential with respect to Generation Uranium Inc.’s industry; (b) market opportunity; (c) Generation Uranium Inc.’s business plans and strategies; (d) services that Generation Uranium Inc. intends to offer; (e) Generation Uranium Inc.’s milestone projections and targets; (f) Generation Uranium Inc.’s expectations regarding receipt of approval for regulatory applications; (g) Generation Uranium Inc.’s intentions to expand into other jurisdictions including the timeline expectations relating to those expansion plans; and (h) Generation Uranium Inc.’s expectations with regarding its ability to deliver shareholder value. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, as of the date of this document including, without limitation, assumptions about: (a) the ability to raise any necessary additional capital on reasonable terms to execute Generation Uranium Inc.’s business plan; (b) that general business and economic conditions will not change in a material adverse manner; (c) Generation Uranium Inc.’s ability to procure equipment and operating supplies in sufficient quantities and on a timely basis; (d) Generation Uranium Inc.’s ability to enter into contractual arrangements with additional parties; (e) the accuracy of budgeted costs and expenditures; (f) Generation Uranium Inc.’s ability to attract and retain skilled personnel; (g) political and regulatory stability; (h) the receipt of governmental, regulatory and third-party approvals, licenses and permits on favorable terms; (i) changes in applicable legislation; (j) stability in financial and capital markets; and (k) expectations regarding the level of disruption to as a result of CV-19. Such forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of Generation Uranium Inc. to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: (a) Generation Uranium Inc.’s operations could be adversely affected by possible future government legislation, policies and controls or by changes in applicable laws and regulations; (b) public health crises such as CV-19 may adversely impact Generation Uranium Inc.’s business; (c) the volatility of global capital markets; (d) political instability and changes to the regulations governing Generation Uranium Inc.’s business operations (e) Generation Uranium Inc. may be unable to implement its growth strategy; and (f) increased competition. Except as required by law, Generation Uranium Inc. undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither does Generation Uranium Inc. nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this document. Neither Generation Uranium Inc. nor any of its representatives shall have any liability whatsoever, under contract, tort, trust or otherwise, to you or any person resulting from the use of the information in this document by you or any of your representatives or for omissions from the information in this document. 7) Any graphs, tables or other information demonstrating the historical performance or current or historical attributes of Generation Uranium Inc. or any other entity contained in this document are intended only to illustrate historical performance or current or historical attributes of Generation Uranium Inc. or such entities and are not necessarily indicative of future performance of Generation Uranium Inc. or such entities. 8) The technical information contained in articles and videos produced for this campaign has been reviewed and approved by Mr. Derrick Strickland, P. Geo, (L5569) at Generation Uranium as the Qualified Person for the Company as defined in National Instrument 43-101. 9) Investing is risky. The information provided in this article should not be considered as a substitute for professional financial consultation. Users should be aware that investing in any form carries inherent risks, and as such, there is a possibility of losing some or all of their investment. The value of investments can fluctuate significantly within a short period, and investors must understand that past performance is not indicative of future results. Additionally, users should exercise caution as transactions involving investments may be irreversible, even in cases of fraud or accidental actions. It is crucial to acknowledge that rapidly evolving laws and technical issues can have adverse effects on the usability, transferability, exchangeability, and value of investments. Furthermore, users must be cognizant of potential security risks associated with their investment activities. Individuals are strongly encouraged to conduct thorough research, seek professional advice, and carefully evaluate their risk tolerance before engaging in any investment endeavors. Market Jar Media Inc. is neither an investment adviser nor a broker-dealer. The information presented on the website is provided for informative purposes only and is not to be treated as a recommendation to make any specific investment. No such information on PressReach.com constitutes advice or a recommendation. Contact Details James Young +1 800-340-9767 campaigns@pressreach.com Company Website https://pressreach.com

August 27, 2024 09:24 AM Eastern Daylight Time

Image
Article thumbnail News Release

E-commerce In The Age Of Artificial Intelligence

Benzinga

By Johnny Rice, Benzinga Dan Wagner, chairperson and CEO of Rezolve (NASDAQ: RZLV), was recently a guest on Benzinga’s All-Access. Rezolve Brain is an AI-powered platform for e-commerce businesses to optimize their online stores with enriched taxonomies, personalized recommendations and a conversational AI-powered shopping interface. Rezolve began trading on the NASDAQ this month. Watch the full interview here: Featured photo by Austin Distel on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

August 27, 2024 09:15 AM Eastern Daylight Time

Video Image
Article thumbnail News Release

Hospital and Health System M&A Remains Active in 2024, Reports Benchmark International

Benchmark International

Benchmark International, a leader in the mergers and acquisition (M&A) industry, has released its latest insights on the hospital and health system M&A landscape, revealing that merger and acquisition activity within the sector remains robust as the healthcare industry continues to navigate challenges and seize opportunities in 2024. According to Benchmark International’s latest report, the dynamics driving M&A activity in the healthcare sector include the need for increased operational efficiency, access to capital, and the pursuit of growth through strategic partnerships. Despite economic headwinds and ongoing regulatory scrutiny, the firm notes that many health systems are actively seeking consolidation opportunities to enhance their competitive positioning, expand service offerings, and ensure long-term sustainability. The report highlights several notable transactions in 2024, demonstrating the diverse motivations behind M&A deals, from scale-driven acquisitions to partnerships focused on expanding access to care. Benchmark International emphasizes that these trends are likely to persist as health systems continue to seek innovative ways to address the evolving demands of the healthcare landscape. As a trusted advisor with extensive experience in the healthcare sector, Benchmark International continues to guide clients through the complexities of M&A transactions, providing strategic insights and support to help them achieve their goals. For more information and to access the full article, please visit https://www.benchmarkintl.com/insights/2024-hospital-and-health-system-ma-remains-active/ ABOUT BENCHMARK INTERNATIONAL: Benchmark International is a global M&A firm that provides business owners with creative, value-maximizing solutions for growing and exiting their businesses. Benchmark International has handled over $11 billion in transaction value across various industries from offices across the world. With decades of M&A experience, Benchmark International’s transaction teams have assisted business owners with achieving their objectives and ensuring the continued growth of their businesses. The firm has also been named the Investment Banking Firm of the Year by The M&A Advisor and the Global M&A Network as well as the #1 Sell-side Exclusive Privately-held M&A Advisor in the World by Pitchbook and Refinitiv's Global League Tables. Contact Details Brittney Zoeller +1 813-898-2350 zoeller@benchmarkintl.com Company Website https://www.benchmarkintl.com/

August 27, 2024 09:00 AM Eastern Daylight Time

Image
Article thumbnail News Release

This Online Gaming And Sportsbook Company Is Looking At Growing In Brazil

Benzinga

By Johnny Rice, Benzinga Brian Goodman, CEO of Golden Matrix Group (NASDAQ: GMGI), was recently a guest on Benzinga’s All-Access. Golden Matrix Group Inc. is an established gaming technology company that develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers, located in the Asia Pacific region. Golden Matrix showed solid growth in its recent Q2 report. Watch the full interview here: Featured photo by Keenan Constance on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

August 27, 2024 09:00 AM Eastern Daylight Time

Video Image
Article thumbnail News Release

LeadStar and RSSA Announce Partnership to Optimize Agent Access for Social Security Education Platform

AmeriLife

LeadStar, the proprietary, private leads platform created with and exclusively for AmeriLife -affiliated agents, announced today that it has partnered with Registered Social Security Analysts (RSSA), a premier organization dedicated to advancing Social Security advisory skills, to offer a new feature to the ever-expanding LeadStar platform and its diverse offerings available. The RSSA partnership is the latest addition to the LeadStar 2.0 platform, which provides a comprehensive set of lead delivery options and new seminar programming. RSSA’s Social Security education platform strengthens agents’ ability to build sales funnels, further their target lead generation outputs, fill seats at seminars, and foster an organic approach to Medicare sales opportunities. “This partnership with RSSA represents a critical addition to LeadStar and is an incredible value-add for AmeriLife’s network of professionals looking to strengthen consumer trust, foster new relationships, build equity, and validate their service offering with their target audiences,” said William DeCourcy, Chief Lead Generation Officer for AmeriLife. "Alongside RSSA, we’re able to deliver educational opportunities to expand agents’ knowledge of Social Security benefits while simultaneously offering them enhanced targeting capabilities for their lead generation options to put this knowledge to greater use.” Key benefits to AmeriLife-affiliated agents include training from Registered Social Security Analysts, who offer a specialized eLearning curriculum with the proprietary RSSA Roadmap Social Security optimization software to help agents navigate complex scenarios and optimize clients' retirement outcomes. Additionally, agents will have access to a library of resource materials, including case studies, white papers, and real-time updates on Social Security regulations, as well as certification opportunities that will distinguish them in their field and enhance their professional credibility. "At RSSA, our mission is to empower professionals with the knowledge they need to guide their clients through one of the most critical aspects of retirement planning—Social Security,” said Ted Rosedale, Vice President of Strategy & Business Development for RSSA. “By partnering with LeadStar, we’re equipping AmeriLife-affiliated agents with the software and knowledge they’ll need to provide exceptional value to their clients. Together, we're not just enhancing lead generation; we're elevating the standard of care and advice consumers can expect when making pivotal retirement decisions." AmeriLife-affiliated licensed agents interested in taking advantage of RSSA educational resources are encouraged to enroll in the eLearning curriculum. For more information about the partnership and to request information, please visit RSSA.com/LeadStar. ### About LeadStar LeadStar is an industry-leading enterprise leads program that delivers the compliant, reliable, and performative leads that today’s health and life insurance agents need to grow their book of business and maximize their success. Powered by AmeriLife and exclusively for the company’s affiliated agents, LeadStar’s suite of solutions includes LeadStar Marketplace, LeadStar Connect, LeadStar Direct, and LeadStar Seminars Powered by LeadingResponse. For more information, contact an AmeriLife-affiliated marketing company or visit LeadStarHub.com. About RSSA RSSA is dedicated to increasing the knowledge and skills of professionals providing Social Security advisory services. RSSA offers training, certification, technology, and support to ensure that financial planners, insurance agents, and other professionals are equipped to advise clients on the best strategies for claiming Social Security benefits. For more information, visit www.rssa.com and www.narssa.org. About AmeriLife AmeriLife’s strength is its mission: to provide insurance and retirement solutions to help people live longer, healthier lives. In doing so, AmeriLife has become recognized as the leader in developing, marketing, and distributing life and health insurance, annuities, and retirement planning solutions to enhance the lives of pre-retirees and retirees across the United States. For over 50 years, AmeriLife has partnered with top insurance carriers to provide value and quality to customers through a distribution network of over 300,000 insurance agents and advisors and 120 marketing organizations and insurance agency locations nationwide. For more information, visit AmeriLife.com and follow AmeriLife on Facebook and LinkedIn. Contact Details RSSA Pamela Kweller media@rssa.com RSSA Partnership Inquiries Ted Rosedale corporatedevelopment@rssa.com AmeriLife Jeff Maldonado media@amerilife.com Partnership Inquiries Patrick Nichols corporatedevelopment@amerilife.com Company Website https://amerilife.com/

August 27, 2024 09:00 AM Eastern Daylight Time

Article thumbnail News Release

Kartoon Studios Reports 38% Sequential Revenue Growth For Q2

Benzinga

By Johnny Rice, Benzinga Andy Heyward, CEO of Kartoon Studios (AMEX: TOON), was recently a guest on Benzinga’s All-Access. Kartoon Studios is a leading global media company that develops, produces, and distributes animated entertainment for kids. The company produces content in-house, like Stan Lee’s Superhero Kindergarten, starring Arnold Schwarzenegger, and acquires properties like Barney. Mr. Heyward spoke to the company’s success in growing revenue and reducing costs over the last quarter. Watch the full interview here: Featured photo by Girl with red hat on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

August 27, 2024 08:55 AM Eastern Daylight Time

Video Image
Article thumbnail News Release

The Potential Of Ketamir-2: A Safer Treatment For Mental Health Disorders And Neuropathic Pain, IND Filing Expected By Year-End

Benzinga

By Meg Flippin, Benzinga Treating mental health is constantly evolving, bringing new therapies and hope to people battling depression, treatment-resistant depression (TRD), post-traumatic stress disorder (PTSD) and other neuropsychiatric conditions. Not all therapies work for everyone, but sometimes an exciting treatment emerges. Ketamine, originally developed as an anesthetic, falls into that category. In recent years, it has been repurposed as a rapid-acting antidepressant, particularly for patients who have not responded to conventional treatments. While often effective, ketamine’s widespread use has been limited by its side effects and low oral bioavailability. Traditional ketamine requires intravenous or intranasal administration, which can be inconvenient and impractical for at-home treatment. Additionally, ketamine’s interaction with multiple receptor sites in the brain can lead to unwanted side effects such as dissociation, hallucinations and, in some cases, psychotic symptoms. Tweaking Ketamine But that doesn’t mean ketamine has to be written off as a new treatment for mental health. It just needs to be tweaked. That’s where MIRA Pharmaceuticals (NASDAQ: MIRA) and Ketamir-2 come in. A pre-clinical-stage pharmaceutical company, MIRA is refining this treatment with its oral ketamine analog, Ketamir-2. MIRA Pharmaceuticals says Ketamir-2 is a groundbreaking compound that has the potential to revolutionize the way mental health disorders and neuropathic pain are treated, offering a safer and more effective alternative to traditional therapies. The company is on track to file an Investigational New Drug (IND) application by the end of the year, marking what it says is a significant milestone in bringing Ketamir-2 closer to clinical trials. Ketamir-2 is designed to overcome the challenges of existing ketamine treatments by creating an agent that is more targeted. Ketamir-2 selectively inhibits the NMDA receptor at the PCP-binding site with 30 to 50 times lower affinity than traditional ketamine. This selective inhibition can reduce the risk of dissociation and hallucinations, providing a cleaner, safer therapeutic experience for patients. Preclinical studies have so far found that Ketamir-2 offers a superior safety profile compared to traditional ketamine. MIRA Pharmaceuticals said one of the most significant findings is that Ketamir-2 does not induce hyper-locomotor activity – a behavior associated with psychotic symptoms – making it a potentially safer option for patients. Better Oral Absorption Could Be Game-changing Another discovery MIRA Pharmaceuticals reports, is Ketamir-2’s non-substrate status for P-glycoprotein (P-gp), a membrane protein that typically limits drug entry into the brain. This means that Ketamir-2 can more effectively cross the blood-brain barrier, leading to better oral absorption and higher efficacy at lower doses. This feature is particularly important for patients seeking convenient, at-home treatment options. On top of all that, MIRA Pharmaceuticals says Ketamir-2’s principal metabolite, Nor-Ketamir, boasts nearly 100% oral bioavailability and sustained plasma residence. This means that once Ketamir-2 is administered orally, it is efficiently metabolized into Nor-Ketamir, which remains in the bloodstream longer, providing extended therapeutic effects. The development of Ketamir-2 Pamoate, a new salt form, further enhances these benefits by ensuring higher plasma and brain levels with a longer half-life, reports the company. Treating Chronic Pain Too Beyond depression and mental health issues, MIRA Pharmaceuticals said studies are ongoing to assess Ketamir-2’s effectiveness in treating neuropathic pain, a chronic and debilitating condition that has an estimated prevalence of 6.9% to 10% worldwide. The dual potential of Ketamir-2 to address both mental health disorders and neuropathic pain could represent a significant advancement in patient care, offering a versatile and effective treatment option. The potential of Ketamir-2 and Nor-Ketamir to offer effective, at-home treatment options for mental health disorders and neuropathic pain could prove to be a game-changer. The convenience of oral administration, combined with the drug’s safety and efficacy, could significantly improve patient adherence to treatment and overall outcomes. Further, the company says toxicology studies have validated Ketamir-2’s safety profile, with no observed toxicity at very high doses in animal models. Ketamine holds a lot of promise in treating mental health but the side effects are limiting adoption. Ketamir-2 could change that by addressing the limitations of traditional ketamine and offering a safer, more effective alternative. If the preclinical trials are any indication, Ketamir-2 could provide hope for many sufferers. For more information about MIRA Pharmaceuticals and its novel compounds, visit MIRA Pharmaceuticals. Featured photo by nikko macaspac on Unsplash Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

August 27, 2024 08:50 AM Eastern Daylight Time

Image
Article thumbnail News Release

Nvidia Is Up Over 150% YTD, But Some Are Flagging Risks – Trade Your Expectation Either Way With REX Shares Leveraged ETFs

Benzinga

By Meg Flippin, Benzinga When it comes to artificial intelligence and machine learning, chip maker Nvidia (NASDAQ: NVDA) has become synonymous with this game-changing and transformative technology. However, it wasn’t always that way. Years ago, Nvidia was known solely for making graphic chips. Recognizing early on the impact AI will have, it shifted focus and never looked back. Since then, Santa Clara, California-based Nvidia has been trailblazing in the AI market, churning out graphic chips that power many of these advanced models. Virtually every technology company, including Amazon.com (NASDAQ: AMZN), Alphabet (NASDAQ: GOOG), Microsoft (NASDAQ: MSFT) and Meta Platforms (NASDAQ: META) use Nvidia chips. At last check, Nvidia was sporting a market capitalization of over $3 trillion. Year-to-date shares are up more than 160%. Over the past five years, it has gained over 3,000%. Earnings On The Horizon Among factors impacting the stock over the past few days is anticipation ahead of the company’s fiscal second-quarter earnings, which Nvidia is slated to report after the close of trading on August 28. Wall Street expects Nvidia to weigh in with EPS of $0.59 per share, which is much higher than the $0.25 Nvidia reported in the year-ago fiscal second quarter. If Nvidia is able to beat that number or post a rosier-than-expected outlook for the remainder of this year and beyond, it could drive the stock higher. Bulls argue Nvidia’s line up of AI chips and processors, which it rolls out on a staggered basis, will be enough to maintain its leading market share position next year and beyond. Bears, however, point to reported delays in its next line of AI chips – dubbed Blackwell processors – as a sign something is amiss. These chips are supposed to be faster and cheaper, but reports have emerged that they are delayed because of design flaws. Investors and analysts will be paying close attention to what Nvidia has to say on that front when it reports earnings. “While the reported delay in Nvidia's Blackwell (i.e., next-generation GPU architecture) could lead to some near-term volatility in fundamentals, we expect management commentary, coupled with supply-chain data points over the coming weeks, to lead to higher conviction regarding Nvidia's earnings power in 2025,” Goldman Sachs wrote in a recent research report. "Importantly, we believe customer demand across large cloud service providers and enterprises is strong, and Nvidia’s robust competitive position in AI/accelerated computing remains intact.” Experiencing Both Worlds With REX Shares ETFs If Nvidia disappoints or offers up a murky outlook, shares could be under pressure. If it beats expectations and signals all is well on the Blackwell front, shares may soar. Whichever way traders believe the much-talked-about stock will go, REX Shares Nvidia-focused ETFs offer the opportunity for traders to potentially profit off their expectations. These leveraged ETFs are funds that use debt or derivatives to increase the returns on the stock. They can potentially generate quicker and larger returns than the tracked asset and provide a way for investors to hedge against a stock going up or down, while at the same time carrying more risk as leveraged instruments. To learn more about leveraged ETFs and what REX Shares has to offer, click here. REX Shares’ T-REX 2X Long NVIDIA Daily Target ETF’s (BATS: NVDX) objective is to magnify the daily performance of the publicly traded common stock of Nvidia toward the upside. The fund seeks daily investment results, before fees and expenses, of 200% of the daily performance of NVDA. The fund does not seek to achieve its stated investment objective for a period of time different from a trading day. Year-to-date, the fund is up more than 350% as of Aug 20. The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. Performance current to the most recent month-end can be obtained by calling 844-802-4004. Short term performance, in particular, is not a good indication of the fund’s future performance, and an investment should not be made based solely on returns. The T-REX 2X Inverse NVIDIA Daily Target ETF (BATS: NVDQ), on the other hand, seeks daily investment results, before fees and expenses, of 200% of the inverse (or opposite) of the daily performance of NVDA. With these two ETFs bears and bulls can get in on the Nvidia journey upward – or downward. For those who would rather play it straighter, REX Shares also offers the REX FANG & Innovation Equity Premium Income ETF (BATS: FEPI), which combines big tech stock exposure and potential for income in a covered call ETF. Among the top holdings of the fund are Nvidia, Amazon, Apple (NASDAQ: AAPL) and Salesforce.com Inc. (NYSE: CRM). When it comes to investing in Nvidia, it may not be for the faint-hearted. The stock has been soaring, but there are also times of volatility. Investors looking to short or long Nvidia can do so with REX Shares ETFs. NVDX and NVDQ do not seek to achieve their stated investment objectives for a period of time different than a trading day. Investing in the Funds is not equivalent to investing directly in NVDA. The Funds are not intended to be used by, and are not appropriate for, investors who do not intend to actively monitor and manage their portfolios. Check out 2x leveraged NVDA ETFs here! Featured photo by Igor Omilaev on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. FOR NVDX STANDARDIZED FUND RETURNS: https://www.rexshares.com/nvdx/ An investor should carefully consider a Fund’s investment objective, risks, charges, and expenses before investing. A Fund’s prospectus and summary prospectus contain this and other information about the REX Shares. To obtain a Fund’s prospectus and summary prospectus call 844-802-4004. A Fund’s prospectus and summary prospectus should be read carefully before investing. Investing in a REX Shares ETF may be more volatile than investing in broadly diversified funds. The use of leverage by a Fund increases the risk to the Fund. The REX Shares ETFs are not suitable for all investors and should be utilized only by sophisticated investors who understand leverage risk, consequences of seeking daily leveraged, or daily inverse leveraged, investment results and intend to actively monitor and manage their investment. NVIDIA Corporation Investing Risk — NVIDIA Corporation faces risks associated with meeting the evolving needs of its large markets – gaming, data center, professional visualization and automotive – and identifying new products, services and technologies; competition in its current and target markets; changes in customer demand. Important Information Regarding 2X NVDA Fund. The T-REX 2x Long NVIDIA Daily Target ETF (NVDX) seeks 2X% daily leveraged investment results and thus will have an increase of volatility relative to the NVDA performance itself. Longer holding periods, higher volatility of NVDA and leverage increase the impact of compounding on an investor’s returns. During periods of higher volatility, the volatility of NVDA may affect the fund’s performance. Important Information Regarding -2X NVDA Fund. The T-REX 2X Inverse NVDA Daily Target ETF (NVDQ) seeks daily inverse investment results and is very different from most other exchange-traded funds. Longer holding periods and higher volatility of NVDA increase the impact of compounding on an investor’s returns. During periods of higher volatility, the volatility of NVDA may affect the fund’s return as much as, or more than, the return of NVDA. Derivatives Risk. Derivatives are financial instruments that derive value from the underlying reference asset or assets, such as stocks, bonds, or funds (including ETFs), interest rates or indexes. Distributor: Foreside Fund Services, LLC, member FINRA, not affiliated with REX Shares or the Funds’ investment advisor. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

August 27, 2024 08:45 AM Eastern Daylight Time

Image
Article thumbnail News Release

Lado Okhotnikov, CEO of Meta Force presented a pilot release of the superhero comic and talked about further developments

Cartel Blue, Inc

In early July 2024, Meta Force released a pilot of the superhero comic and announced ambitious plans to create its own Cinematic Universe (or Extended Universe, or in this case MFEU). Meta Force is a company developing its blockchain-based metaverse Neo Dao. The implementation of a creative project may have seemed like a marketing move, but Lado Okhotnikov, CEO of Meta Force announced plans to release a comic series and create a large-scale MFEU. Lado Okhotnikov presents the comic: Heroes of the New Generation Currently, there is a very well-established idea of what a superhero should be. Marvel, DC, and Japanese manga dominate the media, forming “right” character images. The heroes proposed by Meta Force depart from traditions and stereotypes, they operate in a new world where metaverses become part of our lives. And this is no longer the assumption nor a creative idea of the writers, but reality. The superhero of the Neo Dao metaverse largely transmits the ideas and beliefs of Lado Okhotnikov himself, and the comic book, among others, becomes manifest. Moreover, the pilot is partly autobiographical, similar events happened in the life of the founder of Meta Force, and many heroes have real prototypes. All this is well described by the Meta Force’s slogan: “Virtuality meets reality”. The first pilot gives a general idea of the new hero. He receives superpowers not by chance, not as a gift of fate, but as a result of work and self-improvement. Evil also appears not in the form of traditional villains, but as something mysterious and existential, secretly governing our civilization. The main character’s mission is not so much to defeat enemies physically, but to maintain the balance of the Universe. The main character, Mr. Dao, is philosophical, and charismatic, and has a unique style, in the story, action is successfully combined with reflections. MFEU The basic initial element of modern cineverses was a comic book, around it new formats were built such as cartoons, series, and feature films. That’s how Marvel and DC started. Lado Okhotnikov emphasizes that the comic is the first step in creating its own MFEU. The release dates of the comic continuation and new formats are not specified, it is claimed that this will be soon. About Company Meta Force is the company that created the DeFi platform and developer of Neo Dao metaverse. In two years of operation, the number of users exceeded two million. Lado Okhotnikov is the founder and CEO of Meta Force. Based on Dan Michael’s materials The head of the Meta Force Press Center press@meta-force.space Disclaimer: The Press Release content is being provided by CartelBlue Contact Details Meta Force Dan Michael +1 786-814-1818 press@meta-force.space Company Website https://meta-force.space/

August 27, 2024 07:04 AM Eastern Daylight Time

1 ... 3637383940 ... 3733